These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. Bussolino F; Silvagno F; Garbarino G; Costamagna C; Sanavio F; Arese M; Soldi R; Aglietta M; Pescarmona G; Camussi G J Biol Chem; 1994 Jan; 269(4):2877-86. PubMed ID: 7507929 [TBL] [Abstract][Full Text] [Related]
11. [Ginkgolides antagonizing some effects of platelet-activating factor in vitro]. Dong JC; Li M; Shi ZY Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):606-8. PubMed ID: 8704427 [TBL] [Abstract][Full Text] [Related]
12. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. Coëffier E; Joseph D; Vargaftig BB J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895 [TBL] [Abstract][Full Text] [Related]
13. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures. Nogami K; Hirashima Y; Endo S; Takaku A Brain Res; 1997 Apr; 754(1-2):72-8. PubMed ID: 9134961 [TBL] [Abstract][Full Text] [Related]
14. Platelet activating factor antagonists interact with GABAA receptors. Miller LG; Bazan NG; Roy RB; Clostre F; Gaver A; Braquet P Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):253-6. PubMed ID: 1667341 [TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. Gozal D; Holt GA; Graff GR; Torres JE Am J Physiol; 1998 Aug; 275(2):R604-11. PubMed ID: 9688699 [TBL] [Abstract][Full Text] [Related]
16. Effects of intrastriatal injections of platelet-activating factor and the PAF antagonist BN 52021 on memory. Packard MG; Teather LA; Bazan NG Neurobiol Learn Mem; 1996 Sep; 66(2):176-82. PubMed ID: 8946410 [TBL] [Abstract][Full Text] [Related]
17. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation. Ostermann G; Hofmann B; Kertscher HP; Till U J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154 [TBL] [Abstract][Full Text] [Related]
18. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901 [TBL] [Abstract][Full Text] [Related]
19. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists. Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of PAF-induced tPA release by KO-286011. Klöcking HP Ann N Y Acad Sci; 1992 Dec; 667():202-3. PubMed ID: 1309038 [No Abstract] [Full Text] [Related] [Next] [New Search]